Issues‎ > ‎Vol6n2‎ > ‎

jsmc-10094


PREVALENCE OF FATTY PANCREAS AMONG PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE IN SULAIMANI


Kawa Abdullah Mahmood *


* Department of Surgery, College of Medicine, University of Sulaimani.


Submitted: 7/3/2016; Accepted: 27/6/2017Published: 1/12/2016


ABSTRACT


Background 

Fatty pancreas results from excessive ectopic fat accumulation represents a global health problem recently.

Objectives

To determine the prevalence of fatty pancreas among non alcoholic fatty liver patients and to find out the main risk factors for fatty pancreas.

Patients and Methods

A descriptive prospective observational study conducted at Kurdistan Center for Gastroenterology and Hepatology (KCGH) in Sulaimani governorate through the period from 1st April, 2014 to 31st of April, 2015 on convenient sample of 75 non-alcoholic fatty liver patients. The data was collected by researcher through direct interview and filling of questionnaire included demographic data, weight, height, smoking, drug history, laboratory results of Gamma-Glutamyl transferase (GGT) and lipid profile and ultrasound results of pancreas.

Results

The prevalence of fatty pancreas among patients with non alcoholic fatty liver diseases was 49.3%. Fatty pancreas was significantly predominant among elderly patients 
(p=0.03). Significant higher levels of triglycerides (p=0.03) and GGT (p=0.02) were found among fatty pancreas patients. High density lipoproteins level was significantly lower among fatty pancreas patients (p=0.04).

Conclusion

About half of patients with non alcoholic fatty liver diseases had non alcoholic fatty pancreas;The main risk factors for fatty pancreas were elderly age, male gender, obesity and abnormal lipid profile.

KEYWORDS

Fatty pancreas, Fatty liver, Obesity.

References 
  1. Finucane MM, Stevens GA, Cowan MJ, Danaei G, Lin JK, Singh GM, et al. National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9.1 million participants. Lancet 2011; 377: 557–67.
  2. Ou H-Y, Wang C-Y, Yang Y-C, Chen M-F, Chang C-J. The Association between Nonalcoholic Fatty Pancreas Disease and Diabetes. Sookoian SC, ed. PLoS ONE. 2013; 8(5):e62561. 
  3. Mathur A, Marine M, Lu D, Swartz-Basile DA, Saxena R, Zyromski NJ, et al. Nonalcoholic fatty pancreas disease. HPB (Oxford) 2007; 9:312–18.
  4. Prachayakul V, Aswakul P. Pancreatic Steatosis: What Should Gastroenterologists Know? JOP. J Pancreas (Online) 2015; 16(3):227-31.
  5. Kotronen A, Westerbacka J, Bergholm R, Pietilainen KH, Yki-Jarvinen H. Liver Fat in the Metabolic Syndrome. J ClinEndocrinolMetab 2007; 92: 3490–97.
  6. Targher G, Bertolini L, Poli F, Rodella S, Scala L, Tessari R, et al. Nonalcoholic fatty liver disease and risk of future cardiovascular events among type 2 diabetic patients. Diabetes 2005; 54: 3541–46.
  7. Lee JS, Kim SH, Jun DW, Han JH, Jang EC, Park JY, et al. Clinical implications of fatty pancreas: correlations between fatty pancreas and metabolic syndrome. World J Gastroenterol 2009; 15:1869–75.
  8. Wu WC, Wang CY. Association between non-alcoholic fatty pancreatic disease (NAFPD) and the metabolic syndrome: case–control retrospective study. CardiovascDiabetol. 2013; 12:77.
  9. Sijens PE, Edens MA, Bakker SJ, Stolk RP. MRI determined fat content of human liver, pancreas and kidney. World J Gastroenterol. 2010; 16(16):1993-98.
  10. Smits M, van Geenen E. The clinical significance of pancreatic steatosis. Nat Rev GastroenterolHepatol 2011; 8: 169-77.
  11. Pitt H. Hepato-pancreato-biliary fat: the good, the bad and the ugly. HPB (Oxford) 2007; 9: 92-97.
  12. Lesmana CRA, Pakasi LS, Inggriani S, Aidawati ML, Lesmana LA. Prevalence of Non-Alcoholic Fatty Pancreas Disease (NAFPD) and its risk factors among adult medical check-up patients in a private hospital: a large cross sectional study. BMC Gastroenterology2015; 15:174.
  13. Powis ME, Chang KJ. Endoscopic ultrasound in the clinical staging and management of pancreatic cancer: Its impact on cost of treatment. Cancer Control 2000; 7(5):413–20.
  14. Sandrasegaran K, Lin C, Akisik FM, Tann M. State of the art pancreatic MRI. Am J Rad 2010; 195:42–53.
  15. World Health Organization. Physical status: The use and interpretation of anthropometry: Report of a WHO Expert committee. Technical report series 854, Geneva 1995.
  16. Carter R, Mouralidarane A, Soeda J, Ray S, Pombo J, Sarawati R, et al. Non-Alcoholic Fatty Pancreas Disease Pathogenesis: A Role for Developmental Programming and Altered Circadian Rhythms. Targher G, ed. PLoS ONE. 2014; 9(3):e89505. 
  17. Uygun A, Kadayifci A. The effect of fatty pancreas on serum glucose parameters in patients with nonalcoholic steatohepatitis. European Journal of Internal Medicine 2015; 26: 37–41.
  18. Wang C, Ou H, Chen M, Chang T, Chang C. Enigmatic Ectopic Fat: Prevalence of Nonalcoholic Fatty Pancreas Disease and Its Associated Factors in a Chinese Population. Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease 2014; 3(1):e000297. 
  19. Al Haddad M, Khashab M, Zyromski N, Pungapong S, Wallace MB, Scolapio J, et al. Risk factors for hyperechogenic pancreas on endoscopic ultrasound: a case control study. Pancreas 2009; 38: 672–5.
  20. Sepe PS, Ohri A, Sanaka S, Berzin TM, Sekhon S, Bennett G, et al. A prospective evaluation of fatty pancreas by using EUS. GastrointestEndosc 2011; 73:987–93.
  21. Pinnick KE, Collins SC, Londos C, Gauguier D, Clark A, Fielding BA. Pancreatic ectopic fat is characterized by adipocyte infiltration and altered lipid composition. Obesity (Silver Spring) 2008; 16:522–30.
  22. Patel NS, Peterson MR, Lin GY, Feldstein A, Schnabl B, Bettencourt R, et al. Insulin Resistance Increases MRI-Estimated Pancreatic Fat in Nonalcoholic Fatty Liver Disease and Normal Controls. Gastroenterology Research and Practice 2013; ID 498296, 8 pages. 
  23. Hori M, Takahashi M, Hiraoka N, Yamaji T, Mutoh M, Ishigamori R, et al. Association of Pancreatic Fatty Infiltration with Pancreatic Ductal Adenocarcinoma. Clinical and Translational Gastroenterology. 2014; 5(3):e53.
  24. Choi CW, Kim GH, Kang DH, Kim HW, Kim DU, Heo J, et al. Associated factors for a hyperechogenic pancreas on endoscopic ultrasound. World Journal of Gastroenterology : WJG 2010; 16(34):4329-34.